SmallCapReview.com is a leading small cap stock information site since 1999, to register for the free SmallCapReview newsletter visit http://www.smallcapreview.com.
Sunergy, Inc. (OTCBB: SNEY) Trading at $0.35, Up 20%. Today announced the appointment of Mr. Karl A. Baum as Manager of West African Business Development to further advance the Company's Nyanhin Project within the Republic of Ghana and other business and mining interests in the region.
Mr. Baum brings with him a background in Business Management from Arizona State University and International Management Studies from Thunderbird School of Global Management. He has over 5 years of experience within West Africa serving as the General Manager for (2) small-scale exploration and gold mining operations within The Republic of Ghana with 7,000 ton/day capacity. As International Procurements and Logistics Manager he has overseen the shipment of over USD 15 Million worth of capital equipment from the United States and imported into Ghana. He has led the permitting activities for the operating mines in Ghana and enjoys a good working relationship with the local and national authorities. Prior to his positions within Ghana, Mr. Baum served as Permitting Coordinator on several gold mining projects in Colorado working with the EPA and Division of Minerals and Geology to ensure regulatory compliance.
Mr. Baum has also provided assistance in developing several large scale contracts for mining services within The Republic of Liberia and Sierra Leone; giving him a working knowledge of the customs and concerns of performing within the West African business climate. This hands on experience within the region has assisted him in providing turn-key supply chain management solutions which are vital to successful operations in this part of the world.
What They Do: Sunergy Inc. (SNEY) is an aggressive junior mining exploration and development Company that controls 100% of the 150 SQ. Km. Nyinahin mining concession in Ghana with a full prospecting license.
The concession is surrounded by several operating mines and is adjacent to Newmont Mining's property. This concession has the Ofin river flowing through the eastern portion and there are numerous artisan pits ready for testing and evaluation for near term production. The Ofin river is known for good alluvial gold production. Artisans usually recover about 30% of the available gold through primitive hand methods, leaving 60-70% to be recovered by modern mechanical operations.
SeraCare Life Sciences (Nasdaq: SRLS) Trading at $2.50, Up 49%. Announced Tuesday after market close profitable operational and financial results for its third quarter of fiscal year 2009 ended June 30, 2009. The Company had a net income of $0.7 million and earnings per share on a basic and diluted basis of $0.04 for the quarter ended June 30, 2009 compared to a net loss of $0.6 million and a loss per share on a basic and diluted basis of $0.03 during the same period in 2008.
What They Do: SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics.
Toll Brothers (NYSE: TOL) Trading at $23.08, Up 12%. Today announced preliminary results for its third quarter ended July 31, 2009. FY 2009's third-quarter net signed contracts of approximately 837 units and approximately $447.7 million rose 3% in units and declined 5% in dollars compared to FY 2008's third-quarter totals. The Company's FY 2009 third-quarter home building deliveries and revenues of approximately 792 units and approximately $461.3 million declined 36% in units and 42% in dollars, and its third-quarter-end backlog of approximately 1,626 units and approximately $930.7 million declined 37% in units and 47% in dollars, compared to FY 2008's third-quarter results.
What They Do: Toll Brothers, a FORTUNE 1000 Company, is the only publicly traded national home building company to have won all three of the industry's highest honors: America's Best Builder from the National Association of Home Builders, the National Housing Quality Award, and Builder of the Year.
WuXi PharmaTech (NYSE: WX) Trading at $12.74, Up 21%. Announced Tuesday after market close its financial results for second-quarter 2009.
Net revenues totaled $67.0 million -- Laboratory Services net revenues increased 19% year over year to $61.5 million -- China-based Laboratory Services net revenues grew 26% year over year to $44.8 million -- U.S.-based Laboratory Services net revenues increased 4% year over year to $16.7 million -- Manufacturing Services net revenues decreased 69% year over year to $5.5 million -- GAAP diluted earnings per ADS grew 72% year over year to 20 cents -- Non-GAAP diluted earnings per ADS grew 7% year over year to 24 cents.
What They Do: WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com has been a leading site for news on small-cap stocks since 1999. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select small-cap stocks, to register visit http://www.smallcapreview.com/. SCR has been compensated up to three thousand five hundred dollars by a third party APS for its services with regards to Sunergy Inc.
